FDA Inspection 1090611 — Avara Avlon Pharma Services Ltd.
The FDA completed an inspection of Avara Avlon Pharma Services Ltd. on Mar 22, 2018 in Bristol. The inspection was classified VAI (Voluntary Action Indicated — objectionable conditions or practices were found, but the agency is not prepared to take or recommend any administrative or regulatory action). Product area: Drugs.
Inspection Details
- Classification
- Voluntary Action Indicated (VAI)
- End Date
- Mar 22, 2018
- Fiscal Year
- 2018
- Product Type
- Drugs
- Project Area
- Drug Quality Assurance
- Location
- Bristol (United Kingdom)
Additional Details
Mutual Recognition Agreement (MRA)